UNI-EN 41:CONSOLIDATED ANNUAL AUDITED FINANCIAL STATEMENTS FOR 2015
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 41 | / | 2016 | | ||||||
Date of issue: | 2016-04-28 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
CONSOLIDATED ANNUAL AUDITED FINANCIAL STATEMENTS FOR 2015 | |||||||||||
Official market - legal basis | |||||||||||
Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieї№ce i okresowe | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
CONSOLIDATED ANNUAL AUDITED FINANCIAL STATEMENTS FOR 2015 1. Financial Statements 2. Notes to the Financial Statements 3. Management report 4. Templates of the financial reports approved by the Bulgarian FSC 5. Declaration 6. Auditor’s report | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
SOPHARMA GROUP AUDITED FS 2015.zip SOPHARMA GROUP AUDITED FS 2015.zip | CONSOLIDATED ANNUAL AUDITED FINANCIAL STATEMENTS FOR 2015 |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2016-04-28 | Ognian Donev | Executive Director |
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 5.42 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.